Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSII versus CSII plus sitagliptin in newly diagnosed type 2 diabetes
ChiCTR-TRC-14005224Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Southern Medical University
- Start
- Sep 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of sitagliptin and human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The Third Affiliated Hospital of Southern Medical University. Primary endpoints: Data obtained by continuous glucose monitoring system, SUIT and 4 more. Started Sep 2014; status: recruiting.
02
Drugs
sitagliptinhuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-14005224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005224.